Hong Kong-listed International Business Settlement Holdings Limited has agreed to acquire the entire equity interest in QuantumCompute Solutions Limited for HK$563 million ($72.4 million), in a conditional transaction that would add artificial intelligence chip design and edge-computing capabilities to the group.

The company, known as IBS, entered into the share purchase agreement with seller Brainwave Innovations Limited on October 30, according to its listed-company announcement. The deal remains subject to conditions and a restructuring of the target group. QuantumCompute would become a wholly owned IBS subsidiary when the acquisition is completed.

Target group centers on edge AI chips

QuantumCompute is an investment holding company that indirectly controls Shanghai Tianjing Fulian, an operating business focused on the design and development of AI system-on-chip products and integrated solutions. The business targets low-power AI inference and edge-computing applications, according to the announcement.

IBS said QuantumCompute will indirectly hold about 85.94 percent of Shanghai Tianjing Fulian after a required internal restructuring. Foxconn Industrial Internet separately owns 5.56 percent of the Shanghai company, the announcement said.

The restructuring is a condition precedent to completion. It will place Shanghai Tianjing Fuyu under Tianjing Fulian (Tianjin) and increase Shanghai Tianjing Fuyu’s interest in Shanghai Tianjing Fulian from about 70.28 percent to approximately 85.94 percent.

The ownership chain includes several recently formed holding vehicles. QuantumCompute was incorporated in the British Virgin Islands in June 2026, Neuro Link was incorporated in Hong Kong in July, and Tianjing Fulian (Tianjin) was established in China on October 27, according to the disclosure. Shanghai Tianjing Fuyu, established in 2023, is engaged in AI-chip research and development but remains at an early stage without material operations. Shanghai Tianjing Fulian is identified as the target group’s main operating entity.

The company said Shanghai Tianjing Fulian is an authorized independent chip design house for MediaTek. That status and other product or technology claims are company-supplied and were not independently quantified in the announcement.

IBS seeks to broaden its technology portfolio

IBS currently has businesses spanning fintech-related services and computing-power infrastructure. Its board said the acquisition is intended to move the group further into AI chip design and edge-computing infrastructure while reducing its exposure to cryptocurrency-market volatility.

The buyer plans to continue operating the target’s principal businesses as a standalone operation after completion. IBS also said it does not currently intend to terminate or materially reduce its existing business segments.

The board expects the target’s chip-design capabilities and industry network to create links with the group’s computing infrastructure and fintech businesses. Those expected synergies and growth benefits are forward-looking company assessments rather than completed operating results.

IBS said it has appointed semiconductor executive Tang Tianshen as chief strategic adviser for its fintech-related businesses and to advise on the target after completion. The company cited his previous roles at Intel, Shanghai Hua Hong and Semiconductor Manufacturing International Corporation as relevant experience. His appointment does not remove the execution and integration risks attached to the proposed acquisition.

The acquisition would give IBS access to the target’s personnel, technology assets and existing commercial relationships without building the capabilities internally. The buyer has not provided independently verified market-share, revenue or profitability figures for the chip business in the public release, so the transaction’s financial contribution cannot yet be assessed from those materials.

The transaction is classified as a discloseable transaction under Hong Kong listing rules. IBS also said it will change the use of part of the proceeds from an earlier share subscription to support the acquisition and related development. The Hong Kong exchange filing record lists the October 30 announcement.

Completion timing will depend on the agreement’s conditions, including the target-group restructuring. Until those requirements are met, QuantumCompute and the underlying chip business will remain outside IBS’s consolidated group.

China’s domestic AI stack gains momentum despite hardware gap